Get the Stockscreener App
4.645
1.80%
-0.075
Absci Corp stock is traded at $4.645, with a volume of 2.21M.
It is down -1.80% in the last 24 hours and up +50.98% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$4.72
Open:
$4.71
24h Volume:
2.21M
Relative Volume:
0.55
Market Cap:
$542.12M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-4.9946
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
+24.93%
1M Performance:
+50.98%
6M Performance:
+27.34%
1Y Performance:
+16.75%
1-Day Range:
$4.50
$4.80
1-Week Range:
$3.40
$4.88
52-Week Range:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
4.64 | 542.12M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.27 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.92 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
651.86 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.88 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.98 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Analysts Set Absci Co. (NASDAQ:ABSI) Price Target at $8.57 - MarketBeat
Absci Co. (NASDAQ:ABSI) Receives $8.57 Average Price Target from Brokerages - MarketBeat
ABSI Shares Experience Surge in Value - Knox Daily
Absci (NASDAQ:ABSI) Trading 5.8% HigherStill a Buy? - MarketBeat
ABSI Stock: Exploring Absci Corp’s Growth - The InvestChronicle
A significant driver of top-line growth: Absci Corp (ABSI) - SETE News
Analyzing the Price-to-Earnings Ratio of Absci Corp (ABSI) - The News Heater
ABSI’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
Needham gives a Buy recommendation for Absci Corp (ABSI) - Knox Daily
Absci Co. (NASDAQ:ABSI) Shares Acquired by JPMorgan Chase & Co. - Defense World
Top 5 AI & Digital Biotech Companies (February 2025) - Securities.io
Absci Co. (NASDAQ:ABSI) Short Interest Update - Defense World
Peering Into Absci's Recent Short Interest - Benzinga
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Ballentine Partners LLC Takes $27,000 Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci (NASDAQ:ABSI) Earns Buy Rating from Analysts at Needham & Company LLC - Defense World
Cathie Wood's ARK sells Accolade stock, buys more Absci - MSN
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham - MSN
Cathie Wood's ARK sells Accolade stock, buys more Absci By Investing.com - Investing.com Australia
Absci Stock Surges with “Buy” Ratings from HC Wainwright and Guggenheim: What Investors Should Know - HPBL
Absci Corporation Soars 44% on Strategic AI Drug Discovery Partnership with AMD – Market - HPBL
Absci Corporation and AMD Partner to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci (NASDAQ:ABSI) Now Covered by Needham & Company LLC - MarketBeat
Needham Initiates Coverage of Absci (ABSI) with Buy Recommendation - MSN
TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail
KBW Premium Yield Equity REIT Index (KYX) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail
Absci shares jump as analyst lauds 'practical' AI drug company - The Business Journals
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Benzinga
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Benzinga
Needham initiates Absci shares with Buy rating on strategy By Investing.com - Investing.com Canada
Needham initiates Absci shares with Buy rating on strategy - MSN
Needham & Company LLC Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies - Benzinga
Absci Corporation Partners with AMD to Revolutionize AI-Powered Drug Discovery – Market - HPBL
Absci partners with semiconductor company AMD for AI drug discovery - Mobihealth News
Absci and Owkin synergise TechBio platforms to advance AI drug discovery - European Pharmaceutical Manufacturer
AMD and Absci Collaborate to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership - MSN
Absci Shares Surge 27% on $20M Investment from AMD – Market - HPBL
Absci Co. (NASDAQ:ABSI) Short Interest Up 10.5% in December - MarketBeat
Barclays PLC Buys 104,083 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Complete List of All AI Companies Under $2 Billion Market Cap - Insider Monkey
Absci Corporation (ABSI): AI in Biopharma Discovery - Insider Monkey
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Absci Corp Stock (ABSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
| Redmile Group, LLC | Director |
Mar 01 '24 |
Buy |
4.50 |
222,222 |
999,999 |
8,253,316 |
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):